Article
Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease
27 Nov 2022
Abstract excerpt
Some of the most efficacious antiviral therapeutics are ribonucleos(t)ide analogs. The presence of a 3'-to-5' proofreading exoribonuclease (ExoN) in coronaviruses diminishes the potency of many ribonucleotide analogs. The ability to interfere with ExoN activity will create new possibilities for control of SARS-CoV-2 infection. ExoN is formed by a 1:1 complex of nsp14 and nsp10 proteins. We have purified and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
